Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.47 -0.01 (-0.12%)
As of 08/18/2025 03:54 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.22 billion
P/E Ratio
23.54
Consensus Rating
Strong Buy
Volume
10,101 shares
Average Volume
106,124 shares
Today's Range
$4.30
$4.50
atai Life Sciences stock logo

2. atai Life Sciences NASDAQ:ATAI

$4.05 +0.17 (+4.38%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$4.12 +0.07 (+1.60%)
As of 05:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$777.31 million
P/E Ratio
-5.87
Consensus Rating
Buy
Consensus Price Target
$11.25 (+177.8% Upside)
Volume
5.00 million shares
Average Volume
7.12 million shares
OS Therapies stock logo

3. OS Therapies NYSE:OSTX

$2.18 +0.12 (+5.83%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$2.18 0.00 (0.00%)
As of 05:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$65.15 million
P/E Ratio
-2.53
Consensus Rating
Buy
Consensus Price Target
$18.00 (+725.7% Upside)
Volume
519,676 shares
Average Volume
728,914 shares
Ultrapar Participacoes stock logo

4. Ultrapar Participacoes NYSE:UGP

$3.30 +0.01 (+0.15%)
Closing price 08/18/2025 03:59 PM Eastern
Extended Trading
$3.32 +0.01 (+0.45%)
As of 05:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$3.68 billion
P/E Ratio
7.34
Consensus Rating
Buy
Consensus Price Target
$3.20 (-3.2% Downside)
Volume
1.73 million shares
Average Volume
1.85 million shares
TuHURA Biosciences stock logo

5. TuHURA Biosciences NASDAQ:HURA

$3.09 +0.03 (+0.98%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$3.02 -0.07 (-2.27%)
As of 08/18/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$133.66 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+309.9% Upside)
Volume
355,644 shares
Average Volume
778,649 shares
Today's Range
$3.00
$3.15
OnKure Therapeutics stock logo

6. OnKure Therapeutics NASDAQ:OKUR

$2.80 +0.27 (+10.67%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$2.76 -0.04 (-1.61%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$34.18 million
P/E Ratio
-0.58
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,054.8% Upside)
Volume
158,122 shares
Average Volume
127,280 shares
Climb Bio stock logo

7. Climb Bio NASDAQ:CLYM

$2.11 +0.21 (+11.05%)
As of 08/18/2025 04:00 PM Eastern

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb Bio

Market Capitalization
$128.75 million
P/E Ratio
-3.01
Consensus Rating
Buy
Consensus Price Target
$9.00 (+326.5% Upside)
Volume
1.65 million shares
Average Volume
599,211 shares
Western Copper & Gold stock logo

8. Western Copper & Gold NYSE:WRN

$1.27 -0.08 (-5.93%)
As of 08/18/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$254.70 million
P/E Ratio
-63.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+215.0% Upside)
Volume
326,345 shares
Average Volume
377,121 shares
Quince Therapeutics stock logo

9. Quince Therapeutics NASDAQ:QNCX

$1.67 -0.02 (-1.18%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$1.68 +0.01 (+0.60%)
As of 08/18/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$90.78 million
P/E Ratio
-1.53
Consensus Rating
Buy
Consensus Price Target
$8.14 (+387.6% Upside)
Volume
81,519 shares
Average Volume
216,887 shares
Immunic stock logo

10. Immunic NASDAQ:IMUX

$0.98 +0.08 (+8.55%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$0.99 +0.01 (+1.38%)
As of 05:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$88.92 million
P/E Ratio
-0.80
Consensus Rating
Buy
Consensus Price Target
$7.50 (+666.5% Upside)
Volume
1.28 million shares
Average Volume
1.18 million shares
MannKind stock logo

11. MannKind NASDAQ:MNKD

$3.81 +0.08 (+2.14%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$3.82 +0.00 (+0.13%)
As of 08/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.14 billion
P/E Ratio
34.64
Consensus Rating
Buy
Consensus Price Target
$9.71 (+155.0% Upside)
Volume
2.23 million shares
Average Volume
3.19 million shares
TriSalus Life Sciences stock logo

12. TriSalus Life Sciences NASDAQ:TLSI

$4.86 +0.31 (+6.81%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$4.87 +0.01 (+0.21%)
As of 08/18/2025 04:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$172.17 million
P/E Ratio
-4.12
Consensus Rating
Buy
Consensus Price Target
$10.75 (+121.2% Upside)
Volume
112,146 shares
Average Volume
82,086 shares
Hochschild Mining stock logo

13. Hochschild Mining OTCMKTS:HCHDF

$4.07 -0.01 (-0.25%)
As of 08/18/2025 02:39 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$2.10 billion
Consensus Rating
Buy
Volume
5,325 shares
Average Volume
11,396 shares
Today's Range
$3.85
$4.10
50-Day Range
$3.20
$4.09
Rezolve AI stock logo

14. Rezolve AI NASDAQ:RZLV

$3.43 +0.41 (+13.58%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$3.36 -0.08 (-2.19%)
As of 05:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$628.95 million
Consensus Rating
Buy
Consensus Price Target
$6.36 (+85.3% Upside)
Volume
16.86 million shares
Average Volume
9.85 million shares
Today's Range
$3.04
$3.45
Genelux stock logo

15. Genelux NASDAQ:GNLX

$3.54 -0.02 (-0.56%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$3.60 +0.06 (+1.55%)
As of 08/18/2025 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. More about Genelux

Market Capitalization
$134.47 million
P/E Ratio
-4.12
Consensus Rating
Buy
Consensus Price Target
$17.75 (+401.4% Upside)
Volume
58,820 shares
Average Volume
120,111 shares
Bitcoin Depot stock logo

16. Bitcoin Depot NASDAQ:BTM

$4.04 -0.03 (-0.74%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$4.00 -0.04 (-1.11%)
As of 05:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bitcoin Depot Inc owns and operates a network of cryptocurrency kiosks in North America. Its customers can buy and sell bitcoin, litecoin, and ethereum cryptocurrencies using the BTM kiosk network and other services. More about Bitcoin Depot

Market Capitalization
$261.75 million
P/E Ratio
40.40
Consensus Rating
Buy
Consensus Price Target
$5.67 (+40.3% Upside)
Volume
980,260 shares
Average Volume
1.02 million shares
NRx Pharmaceuticals stock logo

17. NRx Pharmaceuticals NASDAQ:NRXP

$2.76 -0.13 (-4.50%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$2.75 -0.01 (-0.33%)
As of 04:40 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$49.97 million
P/E Ratio
-1.37
Consensus Rating
Buy
Consensus Price Target
$28.50 (+932.6% Upside)
Volume
904,098 shares
Average Volume
283,324 shares
Akebia Therapeutics stock logo

18. Akebia Therapeutics NASDAQ:AKBA

$3.11 -0.14 (-4.31%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$3.12 +0.01 (+0.32%)
As of 05:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Akebia Therapeutics, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. More about Akebia Therapeutics

Market Capitalization
$861.72 million
P/E Ratio
-18.29
Consensus Rating
Buy
Consensus Price Target
$6.75 (+117.0% Upside)
Volume
4.93 million shares
Average Volume
3.98 million shares
zSpace stock logo

19. zSpace NASDAQ:ZSPC

$2.23 -0.01 (-0.45%)
As of 08/18/2025 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$52.18 million
Consensus Rating
Buy
Consensus Price Target
$10.00 (+348.4% Upside)
Volume
98,232 shares
Average Volume
124,855 shares
Today's Range
$2.12
$2.29
Orchestra BioMed stock logo

20. Orchestra BioMed NASDAQ:OBIO

$2.63 +0.06 (+2.33%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$2.66 +0.03 (+1.29%)
As of 08/18/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orchestra BioMed Holdings, Inc operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. More about Orchestra BioMed

Market Capitalization
$99.12 million
P/E Ratio
-1.44
Consensus Rating
Buy
Consensus Price Target
$14.00 (+432.3% Upside)
Volume
348,576 shares
Average Volume
403,624 shares
ImmunityBio stock logo

21. ImmunityBio NASDAQ:IBRX

$2.43 -0.12 (-4.71%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$2.47 +0.04 (+1.65%)
As of 05:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.41 billion
P/E Ratio
-5.06
Consensus Rating
Buy
Consensus Price Target
$10.75 (+342.4% Upside)
Volume
12.13 million shares
Average Volume
9.31 million shares
Mereo BioPharma Group stock logo

22. Mereo BioPharma Group NASDAQ:MREO

$1.68 -0.06 (-3.45%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$1.71 +0.03 (+1.79%)
As of 08/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$276.66 million
P/E Ratio
-24.00
Consensus Rating
Buy
Consensus Price Target
$7.20 (+328.6% Upside)
Volume
743,669 shares
Average Volume
1.70 million shares
FibroBiologics stock logo

23. FibroBiologics NASDAQ:FBLG

$0.62 +0.04 (+7.62%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$0.62 +0.00 (+0.29%)
As of 04:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$24.02 million
P/E Ratio
-1.71
Consensus Rating
Buy
Consensus Price Target
$13.00 (+2,006.3% Upside)
Volume
360,540 shares
Average Volume
496,892 shares
Stardust Power stock logo

24. Stardust Power NASDAQ:SDST

$0.41 +0.00 (+0.89%)
Closing price 08/18/2025 04:00 PM Eastern
Extended Trading
$0.41 0.00 (0.00%)
As of 05:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$24.71 million
P/E Ratio
-0.73
Consensus Rating
Buy
Consensus Price Target
$5.11 (+1,147.0% Upside)
Volume
853,158 shares
Average Volume
3.49 million shares
Ur Energy stock logo

25. Ur Energy NYSEAMERICAN:URG

$1.29 +0.11 (+9.32%)
Closing price 08/18/2025 04:10 PM Eastern
Extended Trading
$1.28 -0.01 (-0.39%)
As of 05:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$430.50 million
P/E Ratio
-7.59
Consensus Rating
Buy
Consensus Price Target
$2.48 (+91.9% Upside)
Volume
7.85 million shares
Average Volume
4.02 million shares